Caraway Therapeutics
Biotechnology, 300 Technology Square, Cambridge, , 2139, Massachusetts, United States, 11-50 Employees
Phone Number: 61********
Who is CARAWAY THERAPEUTICS
A TARGETED APPROACH TO ACTIVATE CELLULAR CLEARANCE Caraways therapeutic approach leverages genetic data and unique biological understanding to develop proprietary small molecules that act...
Read More
-
Headquarters: 300 Technology Square, Cambridge, Massachusetts, 2139, United States
-
Date Founded: 2018
-
Employees: 11-50
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
-
CEO:
Martin Williams
Email
Phone
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from CARAWAY THERAPEUTICS
Caraway Therapeutics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Caraway Therapeutics
Answer: Caraway Therapeutics's headquarters are located at 300 Technology Square, Cambridge, , 2139, Massachusetts, United States
Answer: Caraway Therapeutics's phone number is 61********
Answer: Caraway Therapeutics's official website is https://carawaytx.com
Answer: Caraway Therapeutics's revenue is $25 Million to $50 Million
Answer: Caraway Therapeutics's SIC: 2836
Answer: Caraway Therapeutics's NAICS: 541714
Answer: Caraway Therapeutics has 11-50 employees
Answer: Caraway Therapeutics is in Biotechnology
Answer: Caraway Therapeutics contact info: Phone number: 61******** Website: https://carawaytx.com
Answer: A TARGETED APPROACH TO ACTIVATE CELLULAR CLEARANCE Caraways therapeutic approach leverages genetic data and unique biological understanding to develop proprietary small molecules that activate cellular clearance and recycling processes accelerating clearance of accumulated toxic materials and defective cellular components. New insights in genetics highlight the link between lysosomal function and pathologies in multiple organ systems, including the central nervous system (CNS), heart, kidney, and muscle. Caraway is a leader in targeting these mechanisms with potentially disease-modifying compounds for patients suffering the devastating effects of neurodegenerative and rare diseases including Parkinsons disease (PD), Amyotrophic Lateral Sclerosis (ALS), and lysosomal storage diseases (LSDs).
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month